Investment Rating - The report does not explicitly state an investment rating for the experimental-grade silica gel matrix chromatography filler industry Core Insights - The experimental-grade silica gel matrix chromatography filler industry is experiencing a significant shift towards domestic production, with a current domestic production rate of approximately 40%, expected to rise to 60% by 2030. The pharmaceutical industry is the primary demand driver, particularly due to the rapid growth of the peptide active pharmaceutical ingredient market [4][13][22] Industry Overview - The industry is characterized by a supply chain where upstream silica gel raw materials are dominated by international chemical companies, while the midstream filler preparation market is also led by overseas firms. The downstream applications are diverse, with the pharmaceutical sector being the main area of demand [4][19][20] Market Dynamics - The report highlights that the experimental-grade silica gel matrix chromatography fillers are primarily used for laboratory analysis of organic compounds, natural products, and peptides. The market is expected to grow from approximately 2.15 billion yuan in 2024 to 2.81 billion yuan by 2030, with a compound annual growth rate (CAGR) of 4.5% globally and 10.3% in China [33][36] Technological Trends - Cost reduction and technological innovation are identified as key trends driving the industry. Pharmaceutical companies are increasingly focused on cost control due to the low-profit environment in the generic drug sector, leading to a demand for more cost-effective filler products [10][12] Competitive Landscape - The market is currently fragmented, with major international players like GE, Agilent, and Waters dominating the first tier, while domestic companies are still developing their market presence. The report notes that while the market remains competitive, there is a trend towards consolidation as some domestic firms innovate and differentiate their products [40][41][43]
2025年实验级硅胶基质色谱填料行业词条报告
